Investigation of protective properties of Shigella sonnei carbohydrate biopolymers under experimental endotoxic shock models

[1]  H. Brade,et al.  Endotoxin in Health and Disease , 2020 .

[2]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[3]  K. Tracey,et al.  The "cytokine profile": a code for sepsis. , 2005, Trends in molecular medicine.

[4]  Johan Kuiper,et al.  Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock , 2003, Clinical Microbiology Reviews.

[5]  S. Opal,et al.  Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis. , 2001, The Journal of infectious diseases.

[6]  J. Dhainaut,et al.  LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. , 1999, American journal of respiratory and critical care medicine.

[7]  J. Christman,et al.  Nuclear factor k B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy , 1998, Intensive Care Medicine.

[8]  S. Banks,et al.  Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. , 1995, Journal of immunology.

[9]  A. Wendel,et al.  Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. , 1989, Biochemical pharmacology.

[10]  C. Galanos,et al.  Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice , 1987, The Journal of experimental medicine.

[11]  S. Vogel,et al.  Early-phase endotoxin tolerance: induction by a detoxified lipid A derivative, monophosphoryl lipid A , 1986, Infection and Immunity.

[12]  C. Dinarello,et al.  Cytokines as mediators in the pathogenesis of septic shock. , 1996, Current topics in microbiology and immunology.

[13]  P. Barie,et al.  Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. , 1990, Surgery, gynecology & obstetrics.

[14]  L. Hinshaw.  Pathophysiology of endotoxin , 1985 .